Biogen Alzheimer's Drug Puts FDA's Judgment in Harsh Spotlight https://t.co/2uVAANZo2l
North-East Region
[{'url': 'https://t.co/2uVAANZo2l', 'expanded_url': 'http://dlvr.it/Rrgxv2', 'display_url': 'dlvr.it/Rrgxv2', 'indices': [63, 86]}]
SERANGOON GARDEN
['biogen', "alzheimer's", 'drug', 'put', "fda's", 'judgment', 'harsh', 'spotlight', 'https://t.co/2uvaanzo2l']
['judgment']
biogen drug judgment harsh spotlight
biogen alzheimer drug puts fda judgment harsh spotlight
  [
    {"relatedness": False, "type": "none", "explanation": "This post is not related to maintenance report feedback for public flat houses."},
    ]

The given Twitter post does not seem to be related to a maintenance report feedback for public flat houses. The post is about the FDA's judgment on a drug developed by Biogen for Alzheimer's disease, and does not mention any maintenance or infrastructure issues related to public housing. Therefore, the answer is "False" for the "relatedness" field, and "none" for the "type" field, along with a brief explanation.